These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 404447)

  • 21. [Clinico-bacteriological study of 20 Serratia marcescens infections treated with amikacin].
    Pérez González F; Prendes Peláez P; Meana Fonseca JL; Martín Alvarez R
    Rev Clin Esp; 1981 Jun 15-30; 161(5-6):327-34. PubMed ID: 7027369
    [No Abstract]   [Full Text] [Related]  

  • 22. [Laboratory and clinical studies on amikacin (BB-K8) (author's transl)].
    Kawamori Y; Nishizawa N; Mano D
    Jpn J Antibiot; 1974 Jun; 27(3):348-53. PubMed ID: 4215899
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative clinical effect of amikacin and gentamicin on complicated urinary tract infections by doubld-blind method (author's transl)].
    Nishiura T; Kawada Y; Ichikawa T; Nakano I; Tsuji I; Kumamoto Y; Shishido S
    Nihon Hinyokika Gakkai Zasshi; 1978 Mar; 69(3):381-98. PubMed ID: 351248
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on amikacin (BB-K8) in the urological field (author's transl)].
    Nishimura Y; Takayasu H
    Jpn J Antibiot; 1974 Apr; 27(2):218-22. PubMed ID: 4211656
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical results with amikacin (BB-K8) in respiratory infections (author's transl)].
    Ito T
    Jpn J Antibiot; 1976 Aug; 29(8):731-4. PubMed ID: 957522
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of urinary tract infections with amikacin (BB-K8) (author's transl)].
    Hirokawa I; Nakano I; Okada K; Higaki M; Akima S
    Jpn J Antibiot; 1974 Apr; 27(2):193-201. PubMed ID: 4603934
    [No Abstract]   [Full Text] [Related]  

  • 27. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
    Yu VL; Rhame FS; Pesanti EL; Axline SG
    JAMA; 1977 Aug; 238(9):943-7. PubMed ID: 328950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, epidemiologic and microbiologic features of a persistent outbreak of amikacin-resistant Serratia marcescens.
    Arroyo JC; Milligan WL; Postic B; Northey J; Parker E; Bryan CS
    Infect Control; 1981; 2(5):367-72. PubMed ID: 7028654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [[Fundamental and clinical studies of amikacin (BB-K8) in surgical field (author's transl)]?].
    Shibata K; Fugii M; Shinagawa N; Suzuki Y; Muramatsu
    Jpn J Antibiot; 1974 Oct; 27(5):625-32. PubMed ID: 4218270
    [No Abstract]   [Full Text] [Related]  

  • 30. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of amikacin for respiratory infections (author's transl)].
    Takamoto M; Harada Y; Yamada H; Ishibashi T
    Jpn J Antibiot; 1979 Jun; 32(6):655-60. PubMed ID: 470135
    [No Abstract]   [Full Text] [Related]  

  • 33. [Amikacin treatment of septicemia due to gentamicin-resistant gram-negative bacilli (author's transl)].
    Tomioka H; Kobayashi Y; Tamatani S; Morishita T; Hasegawa Y
    Jpn J Antibiot; 1975 Jun; 28(3):305-8. PubMed ID: 807757
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental studies on the anti-tuberculous effect of BB-K8 (author's transl)].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1975 Aug; 50(8):235-9. PubMed ID: 811917
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R; Hajsig D; Babić I; Mostovac D
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy with amikacin (BB-K8) for bacterial infections in infants and children (author's transl)].
    Nishio T; Kobayashi Y; Akaishi K; Kobayashi Y
    Jpn J Antibiot; 1974 Jun; 27(3):392-400. PubMed ID: 4612188
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of amikacin intravenous therapy in pediatrics (author's transl)].
    Nakazawa S; Sato H; Fujii N; Kojima S; Narita A; Chikaoka H; Oka S
    Jpn J Antibiot; 1980 Oct; 33(10):1104-10. PubMed ID: 7206214
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.
    Lode H; Grunert K; Koeppe P; Langmaack H
    J Infect Dis; 1976 Nov; 134 SUPPL():S316-22. PubMed ID: 825589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical experience with amikacin for respiratory infections due to gentamicin-resistant bacteria (author's transl)].
    Ito T
    Jpn J Antibiot; 1978 Jul; 31(7):346-52. PubMed ID: 691256
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.